Lari B Wenzel

Title(s)Recall Faculty, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-3926
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Stress, Immunity &Cervical Cancer: Biobehavioral Outcomes of a Randomized Trial
    NIH R01CA118136Mar 19, 2007 - Feb 28, 2014
    Role: Principal Investigator
    Psychoneuroimmunology and Cervical Cancer
    NIH R21CA098794Jul 1, 2003 - Jun 30, 2007
    Role: Principal Investigator
    Latina Cervical Cancer Survivorship
    NIH R21CA097191Aug 1, 2002 - Jul 31, 2005
    Role: Principal Investigator
    QUALITY OF LIFE OF GYNECOLOGIC CANCER SURVIVORS
    NIH R01CA079039Sep 10, 1998 - Aug 31, 2001
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005. J Clin Oncol. 2024 Oct 03; JCO2400683. Lee JM, Brady MF, Miller A, Moore RG, MacKay H, McNally L, Lea J, Street D, Lheureux S, McDonald ME, Duska LR, Cantuaria G, Kavecansky J, Leath CA, Powell M, Cadungog MG, Rose PG, Kim YM, Huang HQ, Provencher M, Wenzel LB, Bookman MA, Kohn EC, Secord AA. PMID: 39361946.
      View in: PubMed   Mentions:    Fields:    
    2. Attitudes of physicians and patients toward immediate and intraoperative chemotherapy treatment in colon cancer. Cancer Treat Res Commun. 2024; 39:100798. Jafari MD, Mesiti A, Brouwer J, McKinney C, Wenzel LB, Pigazzi A, Zell JA. PMID: 38447475; PMCID: PMC11332605.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors. Gynecol Oncol. 2024 05; 184:224-235. Kucera CW, Chappell NP, Tian C, Richardson MT, Tarney CM, Hamilton CA, Chan JK, Kapp DS, Leath CA, Casablanca Y, Rojas C, Sitler CA, Wenzel L, Klopp A, Jones NL, Rocconi RP, Farley JH, O'Connor TD, Shriver CD, Bateman NW, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. PMID: 38340648; PMCID: PMC11361276.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. JAMA Netw Open. 2023 04 03; 6(4):e238437. Kucera CW, Tian C, Tarney CM, Presti C, Jokajtys S, Winkler SS, Casablanca Y, Bateman NW, Mhawech-Fauceglia P, Wenzel L, Hamilton CA, Chan JK, Jones NL, Rocconi RP, O'Connor TD, Farley JH, Shriver CD, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. PMID: 37067801; PMCID: PMC10111180.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    5. Phase IIa Clinical Biomarker Trial of Dietary Arginine Restriction and Aspirin in Colorectal Cancer Patients. Cancers (Basel). 2023 Mar 31; 15(7). Zell JA, Taylor TH, Albers CG, Carmichael JC, McLaren CE, Wenzel L, Stamos MJ. PMID: 37046763; PMCID: PMC10093153.
      View in: PubMed   Mentions: 1  
    6. Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors. Gynecol Oncol. 2023 04; 171:151-158. Osann K, Wenzel L, McKinney C, Wagner L, Cella D, Fulci G, Scroggins MJ, Lankes HA, Wang V, Nephew KP, Maxwell GL, Mok SC, Conrads TP, Miller A, Birrer M. PMID: 36905875; PMCID: PMC10681156.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Assessment of Attitudes Toward Initiation of Immediate Adjuvant Chemotherapy for Colon Cancer. J Surg Res. 2023 Mar; 283:658-665. Mesiti AM, Brouwer J, Jafari MD, Qiu Y, Wenzel L, Carmichael J, McKinney C, Zell JA, Pigazzi A. PMID: 36455419; PMCID: PMC10681158.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial. J Clin Oncol. 2022 09 20; 40(27):3115-3119. Yeung AR, Deshmukh S, Klopp AH, Gil KM, Wenzel L, Westin SN, Konski AA, Gaffney DK, Small W, Thompson JS, Doncals DE, Cantuaria GHC, D'Souza DP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. PMID: 35960897; PMCID: PMC9851703.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    9. Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259). J Clin Oncol. 2022 05 01; 40(13):1464-1473. Donovan HS, Sereika SM, Wenzel LB, Edwards RP, Knapp JE, Hughes SH, Roberge MC, Thomas TH, Klein SJ, Spring MB, Nolte S, Landrum LM, Casey AC, Mutch DG, DeBernardo RL, Muller CY, Sullivan SA, Ward SE. PMID: 35130043; PMCID: PMC9061156.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    10. Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial. Lancet. 2022 02 05; 399(10324):541-553. Gershenson DM, Miller A, Brady WE, Paul J, Carty K, Rodgers W, Millan D, Coleman RL, Moore KN, Banerjee S, Connolly K, Secord AA, O'Malley DM, Dorigo O, Gaillard S, Gabra H, Slomovitz B, Hanjani P, Farley J, Churchman M, Ewing A, Hollis RL, Herrington CS, Huang HQ, Wenzel L, Gourley C. PMID: 35123694; PMCID: PMC8819271.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    11. Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study. Gynecol Oncol. 2022 02; 164(2):428-436. Matulonis UA, Huang HQ, Filiaci VL, Randall M, DiSilvestro PA, Moxley KM, Fowler JM, Powell MA, Spirtos NM, Tewari KS, Richards WE, Nakayama JM, Mutch DG, Miller DS, Matei D, Wenzel LB. PMID: 34903380; PMCID: PMC9019849.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    12. Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol. Clin Colorectal Cancer. 2022 06; 21(2):114-121. Jafari MD, Carmichael JC, Dayyani F, McKinney C, Wenzel L, Zell JA, Pigazzi A. PMID: 34980534; PMCID: PMC9844669.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    13. Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. J Natl Cancer Inst. 2021 10 01; 113(10):1369-1378. Wenzel L, Osann K, McKinney C, Cella D, Fulci G, Scroggins MJ, Lankes HA, Wang V, Nephew KP, Maxwell GL, Mok SC, Conrads TP, Miller A, Mannel RS, Gray HJ, Hanjani P, Huh WK, Spirtos N, Leitao MM, Glaser G, Sharma SK, Santin AD, Sperduto P, Lele SB, Burger RA, Monk BJ, Birrer M. PMID: 33729494; PMCID: PMC8486331.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study. Gynecol Oncol. 2021 11; 163(2):392-397. Wenzel L, Huang HQ, Cella D, McKinney CO, Zevon MA, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, von Gruenigen VE. PMID: 34548162; PMCID: PMC8805698.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. BMJ Open. 2021 06 30; 11(6):e045105. Calvert M, King M, Mercieca-Bebber R, Aiyegbusi O, Kyte D, Slade A, Chan AW, Basch E, Bell J, Bennett A, Bhatnagar V, Blazeby J, Bottomley A, Brown J, Brundage M, Campbell L, Cappelleri JC, Draper H, Dueck AC, Ells C, Frank L, Golub RM, Griebsch I, Haywood K, Hunn A, King-Kallimanis B, Martin L, Mitchell S, Morel T, Nelson L, Norquist J, O'Connor D, Palmer M, Patrick D, Price G, Regnault A, Retzer A, Revicki D, Scott J, Stephens R, Turner G, Valakas A, Velikova G, von Hildebrand M, Walker A, Wenzel L. PMID: 34193486; PMCID: PMC8246371.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    16. Longitudinal Changes in Sleep: Associations with Shifts in Circulating Cytokines and Emotional Distress in a Cancer Survivor Population. Int J Behav Med. 2021 Feb; 28(1):140-150. Tucker JA, Osann K, Hsieh S, Wahi A, Monk BJ, Wenzel L, Nelson EL. PMID: 33598780; PMCID: PMC7925505.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecol Oncol. 2021 01; 160(1):244-251. Carter J, Huang HQ, Armer J, Carlson JW, Lockwood S, Nolte S, Kauderer J, Hutson A, Walker JL, Fleury AC, Bonebrake A, Soper JT, Mathews C, Zivanovic O, Richards WE, Tan A, Alberts DS, Barakat RR, Wenzel LB. PMID: 33109392; PMCID: PMC7779696.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    18. Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part II. Gynecol Oncol. 2020 07; 158(1):201-207. Sisodia RC, Dewdney SB, Fader AN, Wethington SL, Melamed A, Von Gruenigen VE, Zivanovic O, Carter J, Cohn DE, Huh W, Wenzel L, Doll K, Cella D, Dowdy SC. PMID: 32580887.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part I. Gynecol Oncol. 2020 07; 158(1):194-200. Sisodia RC, Dewdney SB, Fader AN, Wethington SL, Melamed A, Von Gruenigen VE, Zivanovic O, Carter J, Cohn DE, Huh W, Wenzel L, Doll K, Cella D, Dowdy SC. PMID: 32580886; PMCID: PMC8496422.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Int J Gynecol Cancer. 2020 05; 30(5):596-601. Chase D, Huang HQ, Monk BJ, Ramondetta LM, Penson RT, Gil K, Landrum LM, Leitao M, Oaknin A, Huh WK, Pulaski HL, Robison K, Guntupalli SR, Richardson D, Salani R, Sill MW, Wenzel LB, Tewari KS. PMID: 32114513; PMCID: PMC7780262.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    21. Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. J Clin Oncol. 2020 05 20; 38(15):1685-1692. Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic LA. PMID: 32073955; PMCID: PMC7238486.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    22. GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients. Gynecol Oncol. 2020 02; 156(2):467-474. Carlson JW, Kauderer J, Hutson A, Carter J, Armer J, Lockwood S, Nolte S, Stewart BR, Wenzel L, Walker J, Fleury A, Bonebrake A, Soper J, Mathews C, Zivanovic O, Richards WE, Tan A, Alberts DS, Barakat RR. PMID: 31837831; PMCID: PMC7018616.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    23. Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study. Gynecol Oncol. 2020 01; 156(1):131-139. Mai PL, Huang HQ, Wenzel LB, Han PK, Moser RP, Rodriguez GC, Boggess J, Rutherford TJ, Cohn DE, Kauff ND, Phillips KA, Wilkinson K, Wenham RM, Hamilton C, Powell MA, Walker JL, Greene MH, Hensley ML. PMID: 31759774; PMCID: PMC6980744.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE). Gynecol Oncol. 2019 12; 155(3):452-460. Carter J, Huang HQ, Armer J, Carlson JW, Lockwood S, Nolte S, Stewart BR, Kauderer J, Hutson A, Walker JL, Fleury AC, Bonebrake A, Soper JT, Mathews C, Zivanovic O, Richards WE, Tan A, Alberts DS, Barakat RR, Wenzel L. PMID: 31679787; PMCID: PMC6900449.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecol Oncol. 2019 07; 154(1):183-188. Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Kachnic LA, Bruner DW. PMID: 31104905; PMCID: PMC6918674.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    26. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2019 06 01; 37(16):1380-1390. Walker JL, Brady MF, Wenzel L, Fleming GF, Huang HQ, DiSilvestro PA, Fujiwara K, Alberts DS, Zheng W, Tewari KS, Cohn DE, Powell MA, Van Le L, Davidson SA, Gray HJ, Rose PG, Aghajanian C, Myers T, Alvarez Secord A, Rubin SC, Mannel RS. PMID: 31002578; PMCID: PMC6544459.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    27. Perceptions of changes in clinical, informational, and supportive relationships after end of treatment among parents of young childhood cancer survivors. Psychooncology. 2019 04; 28(4):913-919. Wilford JG, Hopfer S, Wenzel L. PMID: 30812064; PMCID: PMC7853491.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Relationship between social support, quality of life, and Th2 cytokines in a biobehavioral cancer survivorship trial. Support Care Cancer. 2019 Sep; 27(9):3301-3310. Osann K, Wilford J, Wenzel L, Hsieh S, Tucker JA, Wahi A, Monk BJ, Nelson EL. PMID: 30612237; PMCID: PMC6612537.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    29. Controversies among Cancer Registry Participants, Genomic Researchers, and Institutional Review Boards about Returning Participants' Genomic Results. Public Health Genomics. 2018; 21(1-2):18-26. Edwards KL, Goodman D, Johnson CO, Wenzel L, Condit C, Bowen D. PMID: 30227419; PMCID: PMC7833045.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. Validation of PROMIS emotional distress short form scales for cervical cancer. Gynecol Oncol. 2018 10; 151(1):111-116. Wilford J, Osann K, Hsieh S, Monk B, Nelson E, Wenzel L. PMID: 30078504; PMCID: PMC6171766.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    31. Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial. Lancet Oncol. 2018 08; 19(8):1126-1134. Friedlander M, Gebski V, Gibbs E, Davies L, Bloomfield R, Hilpert F, Wenzel LB, Eek D, Rodrigues M, Clamp A, Penson RT, Provencher D, Korach J, Huzarski T, Vidal L, Salutari V, Scott C, Nicoletto MO, Tamura K, Espinoza D, Joly F, Pujade-Lauraine E. PMID: 30026002; PMCID: PMC7869962.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    32. Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants. Support Care Cancer. 2019 Feb; 27(2):531-538. Moss JL, Murphy J, Filiaci VL, Wenzel LB, Minasian L, Temkin SM. PMID: 30003341; PMCID: PMC6330149.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    33. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol. 2018 08 20; 36(24):2538-2544. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. PMID: 29989857; PMCID: PMC6097832.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    34. Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 07; 150(1):119-126. von Gruenigen VE, Huang HQ, Cella D, Zevon M, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, Wenzel L. PMID: 29778506; PMCID: PMC6874212.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    35. A comparison of views regarding the use of de-identified data. Transl Behav Med. 2018 01 29; 8(1):113-118. Goodman D, Johnson CO, Bowen D, Smith M, Wenzel L, Edwards KL. PMID: 29385588; PMCID: PMC6065539.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. The research participant perspective related to the conduct of genomic cohort studies: A systematic review of the quantitative literature. Transl Behav Med. 2018 01 29; 8(1):119-129. Goodman D, Bowen D, Wenzel L, Tehrani P, Fernando F, Khacheryan A, Chowdhury F, Johnson CO, Edwards K. PMID: 29385589; PMCID: PMC6065547.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    37. Quality of Life Among Parents of Adolescent and Young Adult Brain Tumor Survivors. J Pediatr Hematol Oncol. 2017 11; 39(8):579-584. Buchbinder DK, Fortier MA, Osann K, Wilford J, Shen V, Torno L, Sender LS, Parsons SK, Wenzel L. PMID: 28859042; PMCID: PMC5669053.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy. Ann Oncol. 2017 Aug 01; 28(8):1849-1855. Roncolato FT, Gibbs E, Lee CK, Asher R, Davies LC, Gebski VJ, Friedlander M, Hilpert F, Wenzel L, Stockler MR, King M, Pujade-Lauraine E. PMID: 28595285; PMCID: PMC6410892.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    39. De-identified genomic data sharing: the research participant perspective. J Community Genet. 2017 Jul; 8(3):173-181. Goodman D, Johnson CO, Bowen D, Smith M, Wenzel L, Edwards K. PMID: 28382417; PMCID: PMC5496839.
      View in: PubMed   Mentions: 33  
    40. Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients. Contemp Clin Trials. 2017 06; 57:29-36. Wenzel L, Mukamel D, Osann K, Havrilesky L, Sparks L, Lipscomb J, Wright AA, Walker J, Alvarez R, Van Le L, Robison K, Bristow R, Morgan R, Rimel BJ, Ladd H, Hsieh S, Wahi A, Cohn D. PMID: 28330753; PMCID: PMC6198815.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    41. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 04; 145(1):122-129. Mai PL, Piedmonte M, Han PK, Moser RP, Walker JL, Rodriguez G, Boggess J, Rutherford TJ, Zivanovic O, Cohn DE, Thigpen JT, Wenham RM, Friedlander ML, Hamilton CA, Bakkum-Gamez J, Olawaiye AB, Hensley ML, Greene MH, Huang HQ, Wenzel L. PMID: 28190649; PMCID: PMC5359045.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. "She Was a Little Social Butterfly": A Qualitative Analysis of Parent Perception of Social Functioning in Adolescent and Young Adult Brain Tumor Survivors. J Pediatr Oncol Nurs. 2017 Jul/Aug; 34(4):239-249. Wilford J, Buchbinder D, Fortier MA, Osann K, Shen V, Torno L, Sender LS, Parsons SK, Wenzel L. PMID: 28615001; PMCID: PMC6198814.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    43. Views of Cohort Study Participants about Returning Research Results in the Context of Precision Medicine. Public Health Genomics. 2016; 19(5):269-75. Hyams T, Bowen DJ, Condit C, Grossman J, Fitzmaurice M, Goodman D, Wenzel L, Edwards KL. PMID: 27553645; PMCID: PMC5053808.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    44. Consent Issues in Genetic Research: Views of Research Participants. Public Health Genomics. 2016; 19(4):220-8. Goodman D, Johnson CO, Wenzel L, Bowen D, Condit C, Edwards KL. PMID: 27376949; PMCID: PMC4996754.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    45. Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life. Clin Ther. 2016 Mar; 38(3):467-75. Iyer NS, Osann K, Hsieh S, Tucker JA, Monk BJ, Nelson EL, Wenzel L. PMID: 26926320; PMCID: PMC4799758.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    46. Participant views on consent in cancer genetics research: preparing for the precision medicine era. J Community Genet. 2016 Apr; 7(2):133-43. Edwards KL, Korngiebel DM, Pfeifer L, Goodman D, Renz A, Wenzel L, Bowen DJ, Condit CM. PMID: 26801345; PMCID: PMC4796049.
      View in: PubMed   Mentions: 9  
    47. Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice. Gynecol Oncol. 2015 Sep; 138(3):712-6. Cohn DE, Havrilesky LJ, Osann K, Lipscomb J, Hsieh S, Walker JL, Wright AA, Alvarez RD, Karlan BY, Bristow RE, DiSilvestro PA, Wakabayashi MT, Morgan R, Mukamel DB, Wenzel L. PMID: 26177553; PMCID: PMC4920477.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial. J Clin Oncol. 2015 Apr 01; 33(10):1171-9. Wenzel L, Osann K, Hsieh S, Tucker JA, Monk BJ, Nelson EL. PMID: 25713429; PMCID: PMC4372853.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    49. Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204. Int J Gynecol Cancer. 2015 Feb; 25(2):303-8. Chase DM, Kauderer J, Wenzel L, Ramondetta L, Cella D, Long HJ, Monk BJ. PMID: 25405577; PMCID: PMC4506195.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol. 2015 Mar; 16(3):301-11. Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Method M, Michael H, Tewari KS. PMID: 25638326; PMCID: PMC4479218.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    51. Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond. Am Soc Clin Oncol Educ Book. 2015; e299-309. Mackay HJ, Wenzel L, Mileshkin L. PMID: 25993189; PMCID: PMC4920478.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    52. Cervical cancer survivorship: long-term quality of life and social support. Clin Ther. 2015 Jan 01; 37(1):39-48. Pfaendler KS, Wenzel L, Mechanic MB, Penner KR. PMID: 25592090; PMCID: PMC4404405.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    53. Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: characteristics associated with toxicity and the effect of substitution with docetaxel: an NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2015 Feb; 136(2):323-7. Chase DM, Huang H, Foss CD, Wenzel LB, Monk BJ, Burger RA. PMID: 25529832; PMCID: PMC4520309.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    54. A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer. Gynecol Oncol. 2015 Feb; 136(2):293-9. Cohn DE, Barnett JC, Wenzel L, Monk BJ, Burger RA, Straughn JM, Myers ER, Havrilesky LJ. PMID: 25449568; PMCID: PMC4512835.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    55. Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials. Gynecol Oncol. 2014 Nov; 135(2):266-72. Osann K, Hsieh S, Nelson EL, Monk BJ, Chase D, Cella D, Wenzel L. PMID: 25192629; PMCID: PMC4479396.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    56. Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. J Natl Cancer Inst. 2014 Jul; 106(7). Donovan KA, Donovan HS, Cella D, Gaines ME, Penson RT, Plaxe SC, von Gruenigen VE, Bruner DW, Reeve BB, Wenzel L. PMID: 25006190; PMCID: PMC4110471.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    57. Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. J Clin Oncol. 2014 May 01; 32(13):1309-16. Stockler MR, Hilpert F, Friedlander M, King MT, Wenzel L, Lee CK, Joly F, de Gregorio N, Arranz JA, Mirza MR, Sorio R, Freudensprung U, Sneller V, Hales G, Pujade-Lauraine E. PMID: 24687829; PMCID: PMC4876313.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCTClinical Trials
    58. Nursing research in the Gynecologic Oncology Group. Semin Oncol Nurs. 2014 Feb; 30(1):44-52. Donovan HS, Nolte S, Edwards RP, Wenzel L. PMID: 24559780; PMCID: PMC4006357.
      View in: PubMed   Mentions: 2     Fields:    
    59. Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study. Gynecol Oncol. 2013 Mar; 128(3):573-8. Monk BJ, Huang HQ, Burger RA, Mannel RS, Homesley HD, Fowler J, Greer BE, Boente M, Liang SX, Wenzel L. PMID: 23219660; PMCID: PMC4099057.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    60. Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study. Int J Gynecol Cancer. 2012 Nov; 22(9):1624-33. Carter J, Huang H, Chase DM, Walker JL, Cella D, Wenzel L. PMID: 23095778; PMCID: PMC3536465.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    61. Biopsychological stress factors in BRCA mutation carriers. Psychosomatics. 2012 Nov-Dec; 53(6):582-90. Wenzel L, Osann K, Lester J, Kurz R, Hsieh S, Nelson EL, Karlan B. PMID: 23157996; PMCID: PMC4572843.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    62. Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Feb; 128(2):175-80. Hess LM, Brady WE, Havrilesky LJ, Cohn DE, Monk BJ, Wenzel L, Cella D. PMID: 23123576; PMCID: PMC3552113.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    63. The challenge of follow-up in a low-income colposcopy clinic: characteristics associated with noncompliance in high-risk populations. J Low Genit Tract Dis. 2012 Oct; 16(4):345-51. Chase DM, Osann K, Sepina N, Wenzel L, Tewari KS. PMID: 22622340; PMCID: PMC4293035.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    64. Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention. Cancer Prev Res (Phila). 2012 Oct; 5(10):1173-82. Biegler KA, Anderson AK, Wenzel LB, Osann K, Nelson EL. PMID: 22827974; PMCID: PMC4479406.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    65. Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer. Expert Rev Pharmacoecon Outcomes Res. 2012 Jun; 12(3):279-81. Chase DM, Wenzel LB, Monk BJ. PMID: 22812551; PMCID: PMC4920474.
      View in: PubMed   Mentions:    Fields:    
    66. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 May; 125(2):315-9. Chase DM, Huang HQ, Wenzel L, Cella D, McQuellon R, Long HJ, Moore DH, Monk BJ. PMID: 22307062.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    67. Contemporary quality of life issues affecting gynecologic cancer survivors. Hematol Oncol Clin North Am. 2012 Feb; 26(1):169-94. Carter J, Penson R, Barakat R, Wenzel L. PMID: 22244668; PMCID: PMC4572845.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    68. A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Apr; 125(1):54-8. Gould N, Sill MW, Mannel RS, Thaker PH, Disilvestro P, Waggoner S, Yamada SD, Armstrong DK, Wenzel L, Huang H, Fracasso PM, Walker JL. PMID: 22155262; PMCID: PMC3670678.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    69. The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol. 2012 Mar; 124(3):379-82. von Gruenigen VE, Huang HQ, Gil KM, Frasure HE, Armstrong DK, Wenzel LB. PMID: 22119995; PMCID: PMC3278514.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    70. Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Rev Pharmacoecon Outcomes Res. 2011 Aug; 11(4):421-31. Chase DM, Wenzel L. PMID: 21831023; PMCID: PMC4920475.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    71. Survivorship as an element of clinical trials in ovarian cancer. Int J Gynecol Cancer. 2011 May; 21(4):788-92. McAlpine JN, Wenzel LB, Gynecologic Cancer InterGroup. PMID: 21543942; PMCID: PMC4920476.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial. Gynecol Oncol. 2011 Jun 01; 121(3):558-64. Osann K, Wenzel L, Dogan A, Hsieh S, Chase DM, Sappington S, Monk BJ, Nelson EL. PMID: 21402400; PMCID: PMC4572839.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    73. Social Support for Chamorro Breast Cancer Survivors on Guam. Calif J Health Promot. 2010 Dec; 8(Spec iss):63-72. Perez LA, Natividad L, Chung W, Haddock RL, Wenzel L, Hubbell FA. PMID: 25866489; PMCID: PMC4389637.
      View in: PubMed   Mentions: 2  
    74. Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009. Int J Gynecol Cancer. 2010 Oct; 20(7):1290-8. Trimble EL, Birrer MJ, Hoskins WJ, Marth C, Petryshyn R, Quinn M, Thomas GM, Kitchener HC, Gynecologic Cancer Intergroup/National Cancer Institute Writing Committee, Aghajanian C, Alberts DS, Armstrong D, Brown J, Coleman RL, Colombo N, Eisenhauer E, Friedlander M, Fujiwara K, Hunsberger S, Kaye S, Ledermann JA, Lee S, Look K, Mannel R, McNeish IA, Minasian L, Oza A, Paul J, Poveda A, Pujade-Lauraine E, Schoenfeldt M, Swart AM, von Gruenigen V, Wenzel L. PMID: 21151709; PMCID: PMC2998994.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Dec; 119(3):531-7. Cella D, Huang HQ, Monk BJ, Wenzel L, Benda J, McMeekin DS, Cohn D, Ramondetta L, Boardman CH. PMID: 20837359; PMCID: PMC4687012.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    76. Can telephone counseling post-treatment improve psychosocial outcomes among early stage breast cancer survivors? Psychooncology. 2010 Sep; 19(9):923-32. Marcus AC, Garrett KM, Cella D, Wenzel L, Brady MJ, Fairclough D, Pate-Willig M, Barnes D, Emsbo SP, Kluhsman BC, Crane L, Sedlacek S, Flynn PJ. PMID: 19941285; PMCID: PMC2891611.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    77. A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study. J Pain Symptom Manage. 2010 May; 39(5):839-46. von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L. PMID: 20471545; PMCID: PMC3715039.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    78. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2010 Mar; 19(3):648-54. Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Halbert CH. PMID: 20200423; PMCID: PMC2849295.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    79. Potential nonresponse bias in a clinical examination after initial screening using iron phenotyping and HFE genotyping in the hemochromatosis and iron overload screening study. Genet Test Mol Biomarkers. 2009 Dec; 13(6):721-8. Speechley M, Barton JC, Passmore L, Harrison H, Reboussin DM, Harris EL, Rivers CA, Fadojutimi-Akinsiku M, Wenzel L, Diaz S. PMID: 19860558; PMCID: PMC2935839.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    80. Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials. Cancer. 2009 Oct 15; 115(20):4857-64. von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L. PMID: 19691091; PMCID: PMC2761522.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    81. Patient-reported outcomes in sentinel lymph node procedure versus inguinofemoral lymphadenectomy: what is the next step? Gynecol Oncol. 2009 Jun; 113(3):299-300. Wenzel L. PMID: 19426884; PMCID: PMC4572834.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Jul; 110(1):60-4. Wenzel L, Huang HQ, Cella D, Walker JL, Armstrong DK, Gynecologic Oncology Group. PMID: 18430468; PMCID: PMC2587401.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    83. Testing targeted approaches to enhance Cancer Genetics Network minority recruitment within Asian populations. Community Genet. 2008; 11(4):234-40. Wenzel L, Bowen D, Habbal R, Leighton N, Vu T, Anton-Culver H. PMID: 18417971.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    84. Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]. Clin Cancer Res. 2008 Apr 01; 14(7):2111-8. Nelson EL, Wenzel LB, Osann K, Dogan-Ates A, Chantana N, Reina-Patton A, Laust AK, Nishimoto KP, Chicz-DeMet A, du Pont N, Monk BJ. PMID: 18381952; PMCID: PMC4572837.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    85. Cancer-related knowledge, attitudes, and behaviors among Chamorros on Guam. Cancer Detect Prev. 2008; 32 Suppl 1:S4-15. Balajadia RG, Wenzel L, Huh J, Sweningson J, Hubbell FA. PMID: 18359579; PMCID: PMC2441600.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    86. Breast cancer screening among Chamorro women in California. Cancer Detect Prev. 2008; 32 Suppl 1:S16-22. Cruz AL, Chung W, Huh J, Blas LA, Cruz LA, Hubbell FA, Wenzel L. PMID: 18343045; PMCID: PMC2426715.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    87. Supportive care for women with gynecologic cancers. Expert Rev Anticancer Ther. 2008 Feb; 8(2):227-41. Chase DM, Monk BJ, Wenzel LB, Tewari KS. PMID: 18279064.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    88. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007 Nov 10; 25(32):5051-7. Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS, Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G, National Cancer Institute. PMID: 17991920; PMCID: PMC4920473.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    89. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions. J Clin Oncol. 2007 Nov 10; 25(32):5058-62. Wagner LI, Wenzel L, Shaw E, Cella D. PMID: 17991921.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    90. Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop. Gynecol Oncol. 2007 Nov; 107(2):173-6. Bast RC, Thigpen JT, Arbuck SG, Basen-Engquist K, Burke LB, Freedman R, Horning SJ, Ozols R, Rustin GJ, Spriggs D, Wenzel LB, Pazdur R. PMID: 17950384.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    91. Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study. Genet Med. 2007 Oct; 9(10):705-12. Wenzel LB, Anderson R, Tucker DC, Palla S, Thomson E, Speechley M, Harrison H, Lewis-Jack O, Fadojutimi-Akinsiku M, Eckfeldt JH, Reiss JA, Rivers CA, Bookman E, Snively BM, McLaren CE, Hemochromatosis and Iron Overload Study Research Investigators. PMID: 18073584.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    92. Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer. Cancer. 2007 Feb 15; 109(4):645-9. Marth C, Walker JL, Barakat RR, Casado A, Gadducci A, Miller B, Odicino F, Pujade-Lauraine E, Sehouli J, Tropé C, Wenzel L, Zeimet AG. PMID: 17238177.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    93. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007 Feb 01; 25(4):437-43. Wenzel LB, Huang HQ, Armstrong DK, Walker JL, Cella D, Gynecologic Oncology Group. PMID: 17264340.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    94. Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S247-57. Penson RT, Wenzel LB, Vergote I, Cella D. PMID: 17161164.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    95. Impact of hemochromatosis screening in patients with indeterminate results: the hemochromatosis and iron overload screening study. Genet Med. 2006 Nov; 8(11):681-7. Anderson RT, Wenzel L, Walker AP, Ruggiero A, Acton RT, Hall MA, Tucker DC, Thomson E, Harrison B, Howe E, Holup J, Leiendecker-Foster C, Power T, Adams P. PMID: 17108759.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    96. Quality of Life Considerations in Gynecologic Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S247-S257. Penson RT, Wenzel LB, Vergote I, Cella D. PMID: 29644666.
      View in: PubMed   Mentions: 2     Fields:    
    97. Legacy of the Pacific Islander cancer control network. Cancer. 2006 Oct 15; 107(8 Suppl):2091-8. Hubbell FA, Luce PH, Afeaki WP, Cruz LA, McMullin JM, Mummert A, Pouesi J, Reyes ML, Taumoepeau LT, Tu'ufuli GM, Wenzel L. PMID: 16981187.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    98. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006 Jan 05; 354(1):34-43. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA, Gynecologic Oncology Group. PMID: 16394300.
      View in: PubMed   Mentions: 832     Fields:    Translation:HumansCTClinical Trials
    99. Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med. 2005 Oct; 7(8):557-63. Anderson RT, Press N, Tucker DC, Snively BM, Wenzel L, Ellis SD, Hall MA, Walker AP, Thomson EJ, Lewis-Jack O, Acton RT. PMID: 16247294.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    100. Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2005 Aug 20; 23(24):5605-12. Wenzel L, Huang HQ, Monk BJ, Rose PG, Cella D. PMID: 16110020; PMCID: PMC4920482.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    101. Quality of life in ovarian cancer. J Reprod Med. 2005 Jun; 50(6):407-16. Penson R, Cella D, Wenzel L. PMID: 16050565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. Quality of life in long-term cervical cancer survivors. Gynecol Oncol. 2005 May; 97(2):310-7. Wenzel L, DeAlba I, Habbal R, Kluhsman BC, Fairclough D, Krebs LU, Anton-Culver H, Berkowitz R, Aziz N. PMID: 15863123.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    103. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005; (34):94-8. Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, Kluhsman BC, Osann K, Newlands E, Seckl MJ, Hancock B, Cella D. PMID: 15784834; PMCID: PMC6089610.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    104. Addressing the cancer control needs of Pacific Islanders: experience of the Pacific Islander Cancer Control Network. Pac Health Dialog. 2004 Sep; 11(2):233-8. Hubbell FA, Luce PH, Afeaki WP, Cruz LA, Gumataotao T, McMullin JM, Pouesi J, Reyes ML, Taumoepeau LT, Tu'ufuli GM, Wenzel L. PMID: 16281706.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    105. Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med. 2004 Aug; 49(8):589-94. Wenzel L, Berkowitz RS, Habbal R, Newlands E, Hancock B, Goldstein DP, Seckl M, Bernstein M, Strickland S, Higgins J. PMID: 15457848.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med. 2004 Aug; 27(4):373-92. Halbert CH, Schwartz MD, Wenzel L, Narod S, Peshkin BN, Cella D, Lerman C. PMID: 15559734.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    107. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):875-81. Halbert CH, Wenzel L, Lerman C, Peshkin BN, Narod S, Marcus A, Corio C, Demarco T, Bellamy S. PMID: 15159322.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    108. Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A. 2004 Feb 15; 125A(1):5-11. Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT. PMID: 14755459.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    109. Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003 Dec; 17(6):959-68. Garner E, Goldstein DP, Berkowitz RS, Wenzel L. PMID: 14614892.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    110. Cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2009-14. Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. PMID: 14603537.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    111. Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:211-29. Wenzel L, Vergote I, Cella D. PMID: 14763177.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    112. Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol. 2003 Mar 01; 21(5):836-42. Coyne CA, Xu R, Raich P, Plomer K, Dignan M, Wenzel LB, Fairclough D, Habermann T, Schnell L, Quella S, Cella D, Eastern Cooperative Oncology Group. PMID: 12610182.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    113. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol. 2002 Nov; 21(6):564-72. Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C. PMID: 12433008.
      View in: PubMed   Mentions: 143     Fields:    Translation:Humans
    114. Quality of life after gestational trophoblastic disease. J Reprod Med. 2002 May; 47(5):387-94. Wenzel L, Berkowitz RS, Newlands E, Hancock B, Goldstein DP, Seckl MJ, Habbal R, Bernstein M, Kluhsman B, Kulchak-Rahm A, Strickland S, Higgins J. PMID: 12063877.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    115. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology. 2002 Mar-Apr; 11(2):142-53. Wenzel LB, Donnelly JP, Fowler JM, Habbal R, Taylor TH, Aziz N, Cella D. PMID: 11921330.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    116. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002 Jan 15; 107(2):143-50. Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D. PMID: 11807889.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    117. Radiation Therapy Oncology Group. Research Plan 2002-2006. Outcomes Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):66-74. Watkins Bruner D, Berk L, Bondy M, Kachnic LA, Konski A, Layne E, Lee WR, Choucair A, Movsas B, Okunieff P, Roach M, Scott C, Vijayakumar S, Wenzel L, Radiation Therapy Oncology Group. PMID: 11641019.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    118. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):58-9. Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingrin A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A, Radiation Therapy Oncology Group. PMID: 11641017.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. Impact of BRCA1 testing on women with cancer: a pilot study. Genet Test. 2000; 4(3):265-72. Wood ME, Mullineaux L, Rahm AK, Fairclough D, Wenzel L. PMID: 11142757.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    120. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer. 1999 Nov 01; 86(9):1768-74. Wenzel LB, Fairclough DL, Brady MJ, Cella D, Garrett KM, Kluhsman BC, Crane LA, Marcus AC. PMID: 10547550.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    121. Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials. Prev Med. 1999 Mar; 28(3):229-42. Marcus AC, Ahnen D, Cutter G, Calonge N, Russell S, Sedlacek SM, Wood M, Manchester D, Fox L, McCaskill-Stevens W, Fairclough D, Hines S, Wenzel L, Osborn K. PMID: 10072740.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    122. Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial. Psychooncology. 1998 Nov-Dec; 7(6):470-82. Marcus AC, Garrett KM, Cella D, Wenzel LB, Brady MJ, Crane LA, McClatchey MW, Kluhsman BC, Pate-Willig M. PMID: 9885088.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    123. Psychological, social and sexual effects of gestational trophoblastic disease on patients and their partners. J Reprod Med. 1994 Mar; 39(3):163-7. Wenzel LB, Berkowitz RS, Robinson S, Goldstein DP, Bernstein MR. PMID: 8035371.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. The psychological, social, and sexual consequences of gestational trophoblastic disease. Gynecol Oncol. 1992 Jul; 46(1):74-81. Wenzel L, Berkowitz R, Robinson S, Bernstein M, Goldstein D. PMID: 1321784.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Lari's Networks
    Concepts (396)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (22)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California